Company news

hVIVO plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Audited 2017 Preliminary Results

April 19, 2018

Statement regarding share price

April 10, 2018

Initial results from a Phase IIb study of FLU-v

March 26, 2018

Trading Statement

February 15, 2018

Acquisition of Minority Interest

January 23, 2018

Grant of Stock Options

September 14, 2017

Senior Management Appointment

July 25, 2017

Half year end update

July 20, 2017

Board Change

June 20, 2017

Result of Annual General Meeting

May 24, 2017

Award of Deferred Bonus Share Options

May 18, 2017

2016 Annual Report and Financial Statements

April 28, 2017

Proposed amendment to AGM resolution

April 25, 2017

Audited 2016 Preliminary Results

April 20, 2017

Integumen IPO

April 5, 2017

Annual Financial Report & Notice of AGM

March 31, 2017

Issue of Equity

March 29, 2017

Year End Update

March 3, 2017

Initiation of a Phase I clinical trial with AGS-v

February 21, 2017

Data from PrEP Biopharm's Ph. IIa clinical studies

February 9, 2017

Change of auditor

December 30, 2016

Completion of Sale

November 18, 2016

REPLACEMENT - Contract win

November 10, 2016

Contract win

November 8, 2016

Sale of Innovenn UK Limited and Result of GM

October 27, 2016

Sale of Innovenn & Notice of General Meeting

October 4, 2016

Appointment of Non Executive Director

September 22, 2016

hVIVO Landmark Asthma Study Underway

September 2, 2016

Contract wins

August 3, 2016

AGM Statement

June 30, 2016

Shareholder notification

June 20, 2016

Favourable results for PrEP Biopharm's Flu Study

June 14, 2016

Posting of Annual Report and Notice of AGM

June 10, 2016

David Norwood Lock-in Deed

May 24, 2016

2015 Annual Report and Financial Statements

April 28, 2016

Initial results for PrEP Biopharm's Flu study

April 25, 2016

Joint Venture Investment with the SEEK Group

April 22, 2016

Board Changes

April 20, 2016

ESM Schedule 1 update

January 13, 2016

Contracts worth EUR 3.4m signed with US Biotech

January 12, 2016

ESM Pre-Admission Announcement

December 11, 2015

Conditional Placing to raise £20.5 million

November 26, 2015

Grant of Share Option & Total Voting Rights

November 3, 2015

hVIVO invests in PrEP Biopharm Limited

November 2, 2015

Contract for over EUR1m with French Biotech

October 23, 2015

Appointment of Director

October 19, 2015

Result of General Meeting & Update on Acquisition

October 9, 2015

Half Yearly Report

September 24, 2015

Proposed acquisition & Placing

September 22, 2015

Appointment of Co-Broker

August 24, 2015

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.